CA2978442A1 - Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information - Google Patents
Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information Download PDFInfo
- Publication number
- CA2978442A1 CA2978442A1 CA2978442A CA2978442A CA2978442A1 CA 2978442 A1 CA2978442 A1 CA 2978442A1 CA 2978442 A CA2978442 A CA 2978442A CA 2978442 A CA2978442 A CA 2978442A CA 2978442 A1 CA2978442 A1 CA 2978442A1
- Authority
- CA
- Canada
- Prior art keywords
- genes
- disease
- risk
- sample
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 196
- 201000010099 disease Diseases 0.000 title claims abstract description 178
- 238000000034 method Methods 0.000 title claims abstract description 161
- 230000014509 gene expression Effects 0.000 title claims description 70
- 108090000623 proteins and genes Proteins 0.000 claims description 302
- 239000000523 sample Substances 0.000 claims description 221
- 206010028980 Neoplasm Diseases 0.000 claims description 83
- 150000007523 nucleic acids Chemical class 0.000 claims description 77
- 201000011510 cancer Diseases 0.000 claims description 64
- 230000035772 mutation Effects 0.000 claims description 53
- 102000039446 nucleic acids Human genes 0.000 claims description 46
- 108020004707 nucleic acids Proteins 0.000 claims description 46
- 238000004422 calculation algorithm Methods 0.000 claims description 43
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 33
- 230000004927 fusion Effects 0.000 claims description 33
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 claims description 27
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 claims description 27
- 238000012163 sequencing technique Methods 0.000 claims description 26
- -1 CYC1 Proteins 0.000 claims description 23
- 238000004458 analytical method Methods 0.000 claims description 18
- 101001134126 Homo sapiens Nuclear pore membrane glycoprotein 210-like Proteins 0.000 claims description 15
- 101000848718 Homo sapiens Rap guanine nucleotide exchange factor 5 Proteins 0.000 claims description 15
- 101000618138 Homo sapiens Sperm-associated antigen 4 protein Proteins 0.000 claims description 15
- 101000662963 Homo sapiens Transmembrane protein 92 Proteins 0.000 claims description 15
- 101000776449 Homo sapiens Uncharacterized protein C6orf136 Proteins 0.000 claims description 15
- 102100034218 Nuclear pore membrane glycoprotein 210-like Human genes 0.000 claims description 15
- 102100034590 Rap guanine nucleotide exchange factor 5 Human genes 0.000 claims description 15
- 102100021907 Sperm-associated antigen 4 protein Human genes 0.000 claims description 15
- 102100037640 Transmembrane protein 92 Human genes 0.000 claims description 15
- 102100031218 Uncharacterized protein C6orf136 Human genes 0.000 claims description 15
- 230000003321 amplification Effects 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- 102100032025 ETS homologous factor Human genes 0.000 claims description 14
- 101000921245 Homo sapiens ETS homologous factor Proteins 0.000 claims description 14
- 101001067522 Homo sapiens Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 Proteins 0.000 claims description 14
- 101000829538 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 15 Proteins 0.000 claims description 14
- 101000888117 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 18 Proteins 0.000 claims description 14
- 101000742002 Homo sapiens Prickle-like protein 1 Proteins 0.000 claims description 14
- 102100023229 Polypeptide N-acetylgalactosaminyltransferase 15 Human genes 0.000 claims description 14
- 102100038630 Prickle-like protein 1 Human genes 0.000 claims description 14
- 238000012360 testing method Methods 0.000 claims description 14
- 210000001685 thyroid gland Anatomy 0.000 claims description 14
- 101000633605 Homo sapiens Thrombospondin-2 Proteins 0.000 claims description 13
- 102100029529 Thrombospondin-2 Human genes 0.000 claims description 13
- 238000003745 diagnosis Methods 0.000 claims description 13
- 101001065609 Homo sapiens Lumican Proteins 0.000 claims description 12
- 102100032114 Lumican Human genes 0.000 claims description 12
- 101001069684 Homo sapiens Psoriasis susceptibility 1 candidate gene 1 protein Proteins 0.000 claims description 10
- 102100033833 Psoriasis susceptibility 1 candidate gene 1 protein Human genes 0.000 claims description 10
- 238000009396 hybridization Methods 0.000 claims description 9
- 102100028228 COUP transcription factor 1 Human genes 0.000 claims description 8
- 101150016325 EPHA3 gene Proteins 0.000 claims description 8
- 102100030324 Ephrin type-A receptor 3 Human genes 0.000 claims description 8
- 101000860854 Homo sapiens COUP transcription factor 1 Proteins 0.000 claims description 8
- 101000581984 Homo sapiens Neural cell adhesion molecule 2 Proteins 0.000 claims description 8
- 101000700626 Homo sapiens Protein sprouty homolog 3 Proteins 0.000 claims description 8
- 102100030467 Neural cell adhesion molecule 2 Human genes 0.000 claims description 8
- 102100029292 Protein sprouty homolog 3 Human genes 0.000 claims description 8
- 101710186714 2-acylglycerol O-acyltransferase 1 Proteins 0.000 claims description 7
- 102100037039 Acyl-coenzyme A diphosphatase FITM2 Human genes 0.000 claims description 7
- 102100022622 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 claims description 7
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 7
- 102100028202 Cytochrome c oxidase subunit 6C Human genes 0.000 claims description 7
- 102100024469 Dephospho-CoA kinase domain-containing protein Human genes 0.000 claims description 7
- 102100037412 Germinal-center associated nuclear protein Human genes 0.000 claims description 7
- 101710194542 Germinal-center associated nuclear protein Proteins 0.000 claims description 7
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 claims description 7
- 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 claims description 7
- 102100040505 HLA class II histocompatibility antigen, DR alpha chain Human genes 0.000 claims description 7
- 108010086786 HLA-DQA1 antigen Proteins 0.000 claims description 7
- 108010065026 HLA-DQB1 antigen Proteins 0.000 claims description 7
- 108010067802 HLA-DR alpha-Chains Proteins 0.000 claims description 7
- 102100031180 Hereditary hemochromatosis protein Human genes 0.000 claims description 7
- 101000878263 Homo sapiens Acyl-coenzyme A diphosphatase FITM2 Proteins 0.000 claims description 7
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims description 7
- 101000861049 Homo sapiens Cytochrome c oxidase subunit 6C Proteins 0.000 claims description 7
- 101000832260 Homo sapiens Dephospho-CoA kinase domain-containing protein Proteins 0.000 claims description 7
- 101000993059 Homo sapiens Hereditary hemochromatosis protein Proteins 0.000 claims description 7
- 101000730000 Homo sapiens Late secretory pathway protein AVL9 homolog Proteins 0.000 claims description 7
- 101001036258 Homo sapiens Little elongation complex subunit 2 Proteins 0.000 claims description 7
- 101000976899 Homo sapiens Mitogen-activated protein kinase 15 Proteins 0.000 claims description 7
- 101001098523 Homo sapiens PAX-interacting protein 1 Proteins 0.000 claims description 7
- 101001073216 Homo sapiens Period circadian protein homolog 2 Proteins 0.000 claims description 7
- 101000866971 Homo sapiens Putative HLA class I histocompatibility antigen, alpha chain H Proteins 0.000 claims description 7
- 101000606535 Homo sapiens Receptor-type tyrosine-protein phosphatase epsilon Proteins 0.000 claims description 7
- 101000680015 Homo sapiens Thioredoxin-related transmembrane protein 1 Proteins 0.000 claims description 7
- 101000830598 Homo sapiens Tumor necrosis factor ligand superfamily member 12 Proteins 0.000 claims description 7
- 102100032642 Late secretory pathway protein AVL9 homolog Human genes 0.000 claims description 7
- 102100039420 Little elongation complex subunit 2 Human genes 0.000 claims description 7
- 102100023483 Mitogen-activated protein kinase 15 Human genes 0.000 claims description 7
- 102100037141 PAX-interacting protein 1 Human genes 0.000 claims description 7
- 102100035787 Period circadian protein homolog 2 Human genes 0.000 claims description 7
- 102100039665 Receptor-type tyrosine-protein phosphatase epsilon Human genes 0.000 claims description 7
- 108091006555 SLC30A5 Proteins 0.000 claims description 7
- 108091006984 SLC41A3 Proteins 0.000 claims description 7
- 102100037254 Solute carrier family 41 member 3 Human genes 0.000 claims description 7
- 102100022169 Thioredoxin-related transmembrane protein 1 Human genes 0.000 claims description 7
- 102100024584 Tumor necrosis factor ligand superfamily member 12 Human genes 0.000 claims description 7
- 102100026644 Zinc transporter 5 Human genes 0.000 claims description 7
- 238000000540 analysis of variance Methods 0.000 claims description 7
- 238000003752 polymerase chain reaction Methods 0.000 claims description 7
- 102100024338 Collagen alpha-3(VI) chain Human genes 0.000 claims description 6
- 101000909506 Homo sapiens Collagen alpha-3(VI) chain Proteins 0.000 claims description 6
- 101000704156 Homo sapiens Sarcalumenin Proteins 0.000 claims description 6
- 102100031881 Sarcalumenin Human genes 0.000 claims description 6
- 101000984202 Streptomyces rimosus Lipase Proteins 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 108700039887 Essential Genes Proteins 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000012217 deletion Methods 0.000 claims description 5
- 230000037430 deletion Effects 0.000 claims description 5
- 238000009826 distribution Methods 0.000 claims description 5
- 238000003757 reverse transcription PCR Methods 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- 102100040084 A-kinase anchor protein 9 Human genes 0.000 claims description 4
- 102100040176 Archaemetzincin-1 Human genes 0.000 claims description 4
- 102100033890 Arylsulfatase G Human genes 0.000 claims description 4
- 102100021534 Calcium/calmodulin-dependent protein kinase kinase 2 Human genes 0.000 claims description 4
- 102100036568 Cell cycle and apoptosis regulator protein 2 Human genes 0.000 claims description 4
- 102100032348 Coiled-coil domain-containing protein 93 Human genes 0.000 claims description 4
- 102100031611 Collagen alpha-1(III) chain Human genes 0.000 claims description 4
- 102100025177 Dimethylglycine dehydrogenase, mitochondrial Human genes 0.000 claims description 4
- 102100028555 Disheveled-associated activator of morphogenesis 1 Human genes 0.000 claims description 4
- 102100034568 E3 ubiquitin-protein ligase PDZRN3 Human genes 0.000 claims description 4
- 102100028640 HLA class II histocompatibility antigen, DR beta 5 chain Human genes 0.000 claims description 4
- 108010016996 HLA-DRB5 Chains Proteins 0.000 claims description 4
- 101000890598 Homo sapiens A-kinase anchor protein 9 Proteins 0.000 claims description 4
- 101000889842 Homo sapiens Archaemetzincin-1 Proteins 0.000 claims description 4
- 101000925538 Homo sapiens Arylsulfatase G Proteins 0.000 claims description 4
- 101000971617 Homo sapiens Calcium/calmodulin-dependent protein kinase kinase 2 Proteins 0.000 claims description 4
- 101000715194 Homo sapiens Cell cycle and apoptosis regulator protein 2 Proteins 0.000 claims description 4
- 101000797736 Homo sapiens Coiled-coil domain-containing protein 93 Proteins 0.000 claims description 4
- 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 claims description 4
- 101001005618 Homo sapiens Dimethylglycine dehydrogenase, mitochondrial Proteins 0.000 claims description 4
- 101000915413 Homo sapiens Disheveled-associated activator of morphogenesis 1 Proteins 0.000 claims description 4
- 101001131834 Homo sapiens E3 ubiquitin-protein ligase PDZRN3 Proteins 0.000 claims description 4
- 101000598002 Homo sapiens Interferon regulatory factor 1 Proteins 0.000 claims description 4
- 101000613960 Homo sapiens Lysine-specific histone demethylase 1B Proteins 0.000 claims description 4
- 101000967135 Homo sapiens N6-adenosine-methyltransferase catalytic subunit Proteins 0.000 claims description 4
- 101000969961 Homo sapiens Neurexin-3 Proteins 0.000 claims description 4
- 101000969963 Homo sapiens Neurexin-3-beta Proteins 0.000 claims description 4
- 101000614405 Homo sapiens P2X purinoceptor 1 Proteins 0.000 claims description 4
- 101000582936 Homo sapiens Pleckstrin Proteins 0.000 claims description 4
- 101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 claims description 4
- 101000976580 Homo sapiens Zinc finger protein 133 Proteins 0.000 claims description 4
- 102100036981 Interferon regulatory factor 1 Human genes 0.000 claims description 4
- 102100040596 Lysine-specific histone demethylase 1B Human genes 0.000 claims description 4
- 102100040619 N6-adenosine-methyltransferase catalytic subunit Human genes 0.000 claims description 4
- 102100021310 Neurexin-3 Human genes 0.000 claims description 4
- 102100040444 P2X purinoceptor 1 Human genes 0.000 claims description 4
- 102100030264 Pleckstrin Human genes 0.000 claims description 4
- 102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 claims description 4
- 238000000692 Student's t-test Methods 0.000 claims description 4
- 102100023575 Zinc finger protein 133 Human genes 0.000 claims description 4
- 238000002493 microarray Methods 0.000 claims description 4
- 238000000585 Mann–Whitney U test Methods 0.000 claims description 3
- 206010027476 Metastases Diseases 0.000 claims description 3
- 239000000090 biomarker Substances 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000009401 metastasis Effects 0.000 claims description 3
- 238000012353 t test Methods 0.000 claims description 3
- 230000005945 translocation Effects 0.000 claims description 3
- 108700026220 vif Genes Proteins 0.000 claims description 2
- 101000650694 Homo sapiens Roundabout homolog 1 Proteins 0.000 claims 3
- 102100027702 Roundabout homolog 1 Human genes 0.000 claims 3
- 102100030401 Biglycan Human genes 0.000 claims 1
- 101001126865 Homo sapiens Biglycan Proteins 0.000 claims 1
- 101000659053 Homo sapiens Synaptopodin-2 Proteins 0.000 claims 1
- 101000868045 Homo sapiens Uncharacterized protein C1orf87 Proteins 0.000 claims 1
- 101000854800 Homo sapiens V-set and immunoglobulin domain-containing protein 10-like Proteins 0.000 claims 1
- 102100035603 Synaptopodin-2 Human genes 0.000 claims 1
- 102100032994 Uncharacterized protein C1orf87 Human genes 0.000 claims 1
- 102100020801 V-set and immunoglobulin domain-containing protein 10-like Human genes 0.000 claims 1
- 238000013517 stratification Methods 0.000 abstract description 6
- 210000001519 tissue Anatomy 0.000 description 52
- 229920002477 rna polymer Polymers 0.000 description 43
- 210000004027 cell Anatomy 0.000 description 39
- 230000003211 malignant effect Effects 0.000 description 26
- 206010033701 Papillary thyroid cancer Diseases 0.000 description 21
- 230000015654 memory Effects 0.000 description 21
- 208000030045 thyroid gland papillary carcinoma Diseases 0.000 description 20
- 238000003860 storage Methods 0.000 description 19
- 208000024770 Thyroid neoplasm Diseases 0.000 description 18
- 208000035475 disorder Diseases 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 102000053602 DNA Human genes 0.000 description 17
- 201000002510 thyroid cancer Diseases 0.000 description 17
- 230000035945 sensitivity Effects 0.000 description 14
- 208000026350 Inborn Genetic disease Diseases 0.000 description 12
- 208000016361 genetic disease Diseases 0.000 description 12
- 208000030901 thyroid gland follicular carcinoma Diseases 0.000 description 11
- 208000003200 Adenoma Diseases 0.000 description 10
- 208000009956 adenocarcinoma Diseases 0.000 description 10
- 230000002380 cytological effect Effects 0.000 description 10
- 102000040430 polynucleotide Human genes 0.000 description 10
- 108091033319 polynucleotide Proteins 0.000 description 10
- 239000002157 polynucleotide Substances 0.000 description 10
- 238000012706 support-vector machine Methods 0.000 description 10
- 238000004891 communication Methods 0.000 description 9
- 230000003325 follicular Effects 0.000 description 9
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 9
- 230000036438 mutation frequency Effects 0.000 description 9
- 239000002773 nucleotide Substances 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 8
- 238000012549 training Methods 0.000 description 8
- 206010006187 Breast cancer Diseases 0.000 description 7
- 208000026310 Breast neoplasm Diseases 0.000 description 7
- 208000037196 Medullary thyroid carcinoma Diseases 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 208000013818 thyroid gland medullary carcinoma Diseases 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 201000009030 Carcinoma Diseases 0.000 description 6
- 238000003559 RNA-seq method Methods 0.000 description 6
- 238000001574 biopsy Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 208000001446 Anaplastic Thyroid Carcinoma Diseases 0.000 description 5
- 206010025323 Lymphomas Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010038389 Renal cancer Diseases 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000002790 cross-validation Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 201000004260 follicular adenoma Diseases 0.000 description 5
- 208000030878 follicular thyroid adenoma Diseases 0.000 description 5
- 230000003463 hyperproliferative effect Effects 0.000 description 5
- 208000032839 leukemia Diseases 0.000 description 5
- 230000036210 malignancy Effects 0.000 description 5
- 201000001441 melanoma Diseases 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 206010041823 squamous cell carcinoma Diseases 0.000 description 5
- 238000010972 statistical evaluation Methods 0.000 description 5
- 208000019179 thyroid gland undifferentiated (anaplastic) carcinoma Diseases 0.000 description 5
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 4
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 4
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- 210000005131 Hürthle cell Anatomy 0.000 description 4
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 4
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 4
- 201000000582 Retinoblastoma Diseases 0.000 description 4
- 208000024799 Thyroid disease Diseases 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 210000001428 peripheral nervous system Anatomy 0.000 description 4
- 230000003234 polygenic effect Effects 0.000 description 4
- 238000007637 random forest analysis Methods 0.000 description 4
- 201000008440 thyroid gland anaplastic carcinoma Diseases 0.000 description 4
- 206010001233 Adenoma benign Diseases 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- 208000003950 B-cell lymphoma Diseases 0.000 description 3
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 3
- 102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 3
- 206010005003 Bladder cancer Diseases 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 206010061818 Disease progression Diseases 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000024412 Friedreich ataxia Diseases 0.000 description 3
- 102100040196 GRB10-interacting GYF protein 2 Human genes 0.000 description 3
- 208000018565 Hemochromatosis Diseases 0.000 description 3
- 108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 description 3
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 3
- 101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 3
- 101001037074 Homo sapiens GRB10-interacting GYF protein 2 Proteins 0.000 description 3
- 101000919980 Homo sapiens Protoheme IX farnesyltransferase, mitochondrial Proteins 0.000 description 3
- 101000704168 Homo sapiens Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D Proteins 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 208000024556 Mendelian disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108020005196 Mitochondrial DNA Proteins 0.000 description 3
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 3
- 208000003019 Neurofibromatosis 1 Diseases 0.000 description 3
- 208000024834 Neurofibromatosis type 1 Diseases 0.000 description 3
- 206010031096 Oropharyngeal cancer Diseases 0.000 description 3
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 3
- 206010061535 Ovarian neoplasm Diseases 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- 206010036182 Porphyria acute Diseases 0.000 description 3
- 206010060862 Prostate cancer Diseases 0.000 description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
- 102100030729 Protoheme IX farnesyltransferase, mitochondrial Human genes 0.000 description 3
- 208000006265 Renal cell carcinoma Diseases 0.000 description 3
- 102100031878 Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D Human genes 0.000 description 3
- 208000009453 Thyroid Nodule Diseases 0.000 description 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 208000002458 carcinoid tumor Diseases 0.000 description 3
- 201000010881 cervical cancer Diseases 0.000 description 3
- 208000037516 chromosome inversion disease Diseases 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000005750 disease progression Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 238000011532 immunohistochemical staining Methods 0.000 description 3
- 238000003364 immunohistochemistry Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 238000007477 logistic regression Methods 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 238000010801 machine learning Methods 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000001394 metastastic effect Effects 0.000 description 3
- 206010061289 metastatic neoplasm Diseases 0.000 description 3
- 201000006938 muscular dystrophy Diseases 0.000 description 3
- 230000000869 mutational effect Effects 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 201000006958 oropharynx cancer Diseases 0.000 description 3
- 201000010198 papillary carcinoma Diseases 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 201000010174 renal carcinoma Diseases 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 208000007056 sickle cell anemia Diseases 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010044412 transitional cell carcinoma Diseases 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 201000005112 urinary bladder cancer Diseases 0.000 description 3
- 208000010543 22q11.2 deletion syndrome Diseases 0.000 description 2
- 201000010028 Acrocephalosyndactylia Diseases 0.000 description 2
- 206010003571 Astrocytoma Diseases 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 2
- 206010005949 Bone cancer Diseases 0.000 description 2
- 208000018084 Bone neoplasm Diseases 0.000 description 2
- 201000006867 Charcot-Marie-Tooth disease type 4 Diseases 0.000 description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- 208000000398 DiGeorge Syndrome Diseases 0.000 description 2
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010016935 Follicular thyroid cancer Diseases 0.000 description 2
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 2
- 208000009292 Hemophilia A Diseases 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 206010019629 Hepatic adenoma Diseases 0.000 description 2
- 208000008051 Hereditary Nonpolyposis Colorectal Neoplasms Diseases 0.000 description 2
- 208000017095 Hereditary nonpolyposis colon cancer Diseases 0.000 description 2
- 208000017604 Hodgkin disease Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000701806 Human papillomavirus Species 0.000 description 2
- 208000023105 Huntington disease Diseases 0.000 description 2
- 208000025500 Hutchinson-Gilford progeria syndrome Diseases 0.000 description 2
- 206010021042 Hypopharyngeal cancer Diseases 0.000 description 2
- 206010056305 Hypopharyngeal neoplasm Diseases 0.000 description 2
- 208000007766 Kaposi sarcoma Diseases 0.000 description 2
- 208000027747 Kennedy disease Diseases 0.000 description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 description 2
- 206010023825 Laryngeal cancer Diseases 0.000 description 2
- 208000002404 Liver Cell Adenoma Diseases 0.000 description 2
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 2
- 201000005027 Lynch syndrome Diseases 0.000 description 2
- 208000008948 Menkes Kinky Hair Syndrome Diseases 0.000 description 2
- 208000012583 Menkes disease Diseases 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
- 208000014767 Myeloproliferative disease Diseases 0.000 description 2
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 208000034176 Neoplasms, Germ Cell and Embryonal Diseases 0.000 description 2
- 208000014060 Niemann-Pick disease Diseases 0.000 description 2
- 238000010826 Nissl staining Methods 0.000 description 2
- 208000035544 Nonketotic hyperglycinaemia Diseases 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 201000009928 Patau syndrome Diseases 0.000 description 2
- 201000011252 Phenylketonuria Diseases 0.000 description 2
- 206010036186 Porphyria non-acute Diseases 0.000 description 2
- 208000007932 Progeria Diseases 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 208000006289 Rett Syndrome Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 208000027077 Stickler syndrome Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 208000022292 Tay-Sachs disease Diseases 0.000 description 2
- 208000024313 Testicular Neoplasms Diseases 0.000 description 2
- 206010057644 Testis cancer Diseases 0.000 description 2
- 208000000728 Thymus Neoplasms Diseases 0.000 description 2
- 206010044686 Trisomy 13 Diseases 0.000 description 2
- 208000006284 Trisomy 13 Syndrome Diseases 0.000 description 2
- 208000002495 Uterine Neoplasms Diseases 0.000 description 2
- 210000001766 X chromosome Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 201000008279 amyotrophic lateral sclerosis type 4 Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 208000035269 cancer or benign tumor Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 201000011205 glycine encephalopathy Diseases 0.000 description 2
- 201000009277 hairy cell leukemia Diseases 0.000 description 2
- 201000002735 hepatocellular adenoma Diseases 0.000 description 2
- 201000006866 hypopharynx cancer Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 201000010982 kidney cancer Diseases 0.000 description 2
- 206010023841 laryngeal neoplasm Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000006178 malignant mesothelioma Diseases 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 206010027191 meningioma Diseases 0.000 description 2
- 208000005135 methemoglobinemia Diseases 0.000 description 2
- 208000028260 mitochondrial inheritance Diseases 0.000 description 2
- 230000023202 mitochondrion inheritance Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 208000007538 neurilemmoma Diseases 0.000 description 2
- 208000002761 neurofibromatosis 2 Diseases 0.000 description 2
- 208000029974 neurofibrosarcoma Diseases 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 201000006790 nonsyndromic deafness Diseases 0.000 description 2
- 201000005443 oral cavity cancer Diseases 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 210000000277 pancreatic duct Anatomy 0.000 description 2
- 230000000849 parathyroid Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 238000003196 serial analysis of gene expression Methods 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 208000002320 spinal muscular atrophy Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 201000003120 testicular cancer Diseases 0.000 description 2
- 208000008732 thymoma Diseases 0.000 description 2
- 201000009377 thymus cancer Diseases 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- 206010046766 uterine cancer Diseases 0.000 description 2
- 230000009790 vascular invasion Effects 0.000 description 2
- 206010000021 21-hydroxylase deficiency Diseases 0.000 description 1
- 102100036512 7-dehydrocholesterol reductase Human genes 0.000 description 1
- VZCCTDLWCKUBGD-UHFFFAOYSA-N 8-[[4-(dimethylamino)phenyl]diazenyl]-10-phenylphenazin-10-ium-2-amine;chloride Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1N=NC1=CC=C(N=C2C(C=C(N)C=C2)=[N+]2C=3C=CC=CC=3)C2=C1 VZCCTDLWCKUBGD-UHFFFAOYSA-N 0.000 description 1
- 102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000005452 Acute intermittent porphyria Diseases 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 108700037034 Adenylosuccinate lyase deficiency Proteins 0.000 description 1
- 208000028060 Albright disease Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010068783 Alstroem syndrome Diseases 0.000 description 1
- 201000005932 Alstrom Syndrome Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010061424 Anal cancer Diseases 0.000 description 1
- 206010002240 Anaplastic thyroid cancer Diseases 0.000 description 1
- 206010056292 Androgen-Insensitivity Syndrome Diseases 0.000 description 1
- 101710081722 Antitrypsin Proteins 0.000 description 1
- 208000007860 Anus Neoplasms Diseases 0.000 description 1
- 208000025490 Apert syndrome Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 101100328890 Arabidopsis thaliana COL3 gene Proteins 0.000 description 1
- 101100328894 Arabidopsis thaliana COL6 gene Proteins 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 206010061666 Autonomic neuropathy Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 201000007791 Beare-Stevenson cutis gyrata syndrome Diseases 0.000 description 1
- 206010004593 Bile duct cancer Diseases 0.000 description 1
- 208000033929 Birt-Hogg-Dubé syndrome Diseases 0.000 description 1
- 201000004940 Bloch-Sulzberger syndrome Diseases 0.000 description 1
- 208000005692 Bloom Syndrome Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010048409 Brain malformation Diseases 0.000 description 1
- 201000003642 Brittle cornea syndrome Diseases 0.000 description 1
- 208000029402 Bulbospinal muscular atrophy Diseases 0.000 description 1
- 206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 208000022526 Canavan disease Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
- 208000005024 Castleman disease Diseases 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 1
- 201000006892 Charcot-Marie-Tooth disease type 1 Diseases 0.000 description 1
- 208000035758 Charcot-Marie-Tooth disease type 2S Diseases 0.000 description 1
- 206010008723 Chondrodystrophy Diseases 0.000 description 1
- 208000016718 Chromosome Inversion Diseases 0.000 description 1
- 206010009269 Cleft palate Diseases 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 208000010200 Cockayne syndrome Diseases 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 208000001353 Coffin-Lowry syndrome Diseases 0.000 description 1
- 102100029136 Collagen alpha-1(II) chain Human genes 0.000 description 1
- 208000006992 Color Vision Defects Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
- 208000034958 Congenital erythropoietic porphyria Diseases 0.000 description 1
- 206010010510 Congenital hypothyroidism Diseases 0.000 description 1
- 206010010543 Congenital methaemoglobinaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000012437 Copper-Transporting ATPases Human genes 0.000 description 1
- 208000012609 Cowden disease Diseases 0.000 description 1
- 201000002847 Cowden syndrome Diseases 0.000 description 1
- 206010066946 Craniofacial dysostosis Diseases 0.000 description 1
- 206010011385 Cri-du-chat syndrome Diseases 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 201000006526 Crouzon syndrome Diseases 0.000 description 1
- 201000001200 Crouzon syndrome-acanthosis nigricans syndrome Diseases 0.000 description 1
- 208000037461 Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000024940 Dent disease Diseases 0.000 description 1
- 208000035976 Developmental Disabilities Diseases 0.000 description 1
- 206010061819 Disease recurrence Diseases 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 208000006402 Ductal Carcinoma Diseases 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 102100024108 Dystrophin Human genes 0.000 description 1
- 101150029707 ERBB2 gene Proteins 0.000 description 1
- 208000024323 Ehlers-Danlos syndrome dermatosparaxis type Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 208000007209 Erythropoietic Porphyria Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 208000012468 Ewing sarcoma/peripheral primitive neuroectodermal tumor Diseases 0.000 description 1
- 208000005917 Exostoses Diseases 0.000 description 1
- 201000003727 FG syndrome Diseases 0.000 description 1
- 239000009484 FIBS Substances 0.000 description 1
- 208000024720 Fabry Disease Diseases 0.000 description 1
- 208000028771 Facial injury Diseases 0.000 description 1
- 201000003542 Factor VIII deficiency Diseases 0.000 description 1
- 208000005050 Familial Hypophosphatemic Rickets Diseases 0.000 description 1
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 description 1
- 201000004939 Fanconi anemia Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007659 Fibroadenoma Diseases 0.000 description 1
- 208000001914 Fragile X syndrome Diseases 0.000 description 1
- 102000034286 G proteins Human genes 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 208000027472 Galactosemias Diseases 0.000 description 1
- 108010001517 Galectin 3 Proteins 0.000 description 1
- 102100039558 Galectin-3 Human genes 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 description 1
- 208000015872 Gaucher disease Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102100033495 Glycine dehydrogenase (decarboxylating), mitochondrial Human genes 0.000 description 1
- 208000016621 Hearing disease Diseases 0.000 description 1
- 101100327243 Hemicentrotus pulcherrimus CYCE gene Proteins 0.000 description 1
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000003591 Hepatoerythropoietic Porphyria Diseases 0.000 description 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
- 208000000627 Hereditary Coproporphyria Diseases 0.000 description 1
- 208000032087 Hereditary Leber Optic Atrophy Diseases 0.000 description 1
- 206010069382 Hereditary neuropathy with liability to pressure palsies Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101000771163 Homo sapiens Collagen alpha-1(II) chain Proteins 0.000 description 1
- 101001053946 Homo sapiens Dystrophin Proteins 0.000 description 1
- 101001067100 Homo sapiens Uroporphyrinogen-III synthase Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010020608 Hypercoagulation Diseases 0.000 description 1
- 208000001021 Hyperlipoproteinemia Type I Diseases 0.000 description 1
- 208000008852 Hyperoxaluria Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020864 Hypertrichosis Diseases 0.000 description 1
- 206010053574 Immunoblastic lymphoma Diseases 0.000 description 1
- 208000007031 Incontinentia pigmenti Diseases 0.000 description 1
- 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 description 1
- 108010036012 Iodide peroxidase Proteins 0.000 description 1
- 208000009289 Jackson-Weiss syndrome Diseases 0.000 description 1
- 201000008645 Joubert syndrome Diseases 0.000 description 1
- 102100032700 Keratin, type I cytoskeletal 20 Human genes 0.000 description 1
- 108010066370 Keratin-20 Proteins 0.000 description 1
- 208000017924 Klinefelter Syndrome Diseases 0.000 description 1
- 208000028226 Krabbe disease Diseases 0.000 description 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 1
- 201000000639 Leber hereditary optic neuropathy Diseases 0.000 description 1
- 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
- 201000004462 Leydig Cell Tumor Diseases 0.000 description 1
- 201000011062 Li-Fraumeni syndrome Diseases 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- 208000004059 Male Breast Neoplasms Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
- 208000032271 Malignant tumor of penis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000000916 Mandibulofacial dysostosis Diseases 0.000 description 1
- 201000001853 McCune-Albright syndrome Diseases 0.000 description 1
- 208000021964 McLeod neuroacanthocytosis syndrome Diseases 0.000 description 1
- 208000026486 McLeod syndrome Diseases 0.000 description 1
- 208000007054 Medullary Carcinoma Diseases 0.000 description 1
- 208000009018 Medullary thyroid cancer Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000037431 Micro syndrome Diseases 0.000 description 1
- 208000037699 Monosomy 18p Diseases 0.000 description 1
- 208000001804 Monosomy 5p Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 208000003090 Mowat-Wilson syndrome Diseases 0.000 description 1
- 208000007326 Muenke Syndrome Diseases 0.000 description 1
- 208000008770 Multiple Hamartoma Syndrome Diseases 0.000 description 1
- 208000003452 Multiple Hereditary Exostoses Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010068871 Myotonic dystrophy Diseases 0.000 description 1
- 208000031790 Neonatal hemochromatosis Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 201000004404 Neurofibroma Diseases 0.000 description 1
- 208000009905 Neurofibromatoses Diseases 0.000 description 1
- 206010029748 Noonan syndrome Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010031243 Osteogenesis imperfecta Diseases 0.000 description 1
- 101000989950 Otolemur crassicaudatus Hemoglobin subunit alpha-A Proteins 0.000 description 1
- 201000010810 Otospondylomegaepiphyseal dysplasia Diseases 0.000 description 1
- 102100024127 Pantothenate kinase 2, mitochondrial Human genes 0.000 description 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000004843 Pendred Syndrome Diseases 0.000 description 1
- 208000002471 Penile Neoplasms Diseases 0.000 description 1
- 206010034299 Penile cancer Diseases 0.000 description 1
- 206010034620 Peripheral sensory neuropathy Diseases 0.000 description 1
- 206010034764 Peutz-Jeghers syndrome Diseases 0.000 description 1
- 201000004014 Pfeiffer syndrome Diseases 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 241000097929 Porphyria Species 0.000 description 1
- 201000010273 Porphyria Cutanea Tarda Diseases 0.000 description 1
- 208000033141 Porphyria variegata Diseases 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 201000010769 Prader-Willi syndrome Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000005660 Protein C Deficiency Diseases 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 206010051292 Protein S Deficiency Diseases 0.000 description 1
- 102100028680 Protein patched homolog 1 Human genes 0.000 description 1
- 101710161390 Protein patched homolog 1 Proteins 0.000 description 1
- 102100029028 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 208000035955 Proximal myotonic myopathy Diseases 0.000 description 1
- 201000004613 Pseudoxanthoma elasticum Diseases 0.000 description 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010039281 Rubinstein-Taybi syndrome Diseases 0.000 description 1
- BFDMCHRDSYTOLE-UHFFFAOYSA-N SC#N.NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 Chemical compound SC#N.NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 BFDMCHRDSYTOLE-UHFFFAOYSA-N 0.000 description 1
- 208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
- 206010061934 Salivary gland cancer Diseases 0.000 description 1
- 208000021811 Sandhoff disease Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 208000003274 Sertoli cell tumor Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 201000007410 Smith-Lemli-Opitz syndrome Diseases 0.000 description 1
- 208000032383 Soft tissue cancer Diseases 0.000 description 1
- 208000037140 Steinert myotonic dystrophy Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010069116 Tetrahydrobiopterin deficiency Diseases 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 102100027188 Thyroid peroxidase Human genes 0.000 description 1
- 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
- 201000003199 Treacher Collins syndrome Diseases 0.000 description 1
- 241000041303 Trigonostigma heteromorpha Species 0.000 description 1
- 208000026911 Tuberous sclerosis complex Diseases 0.000 description 1
- 208000026928 Turner syndrome Diseases 0.000 description 1
- 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
- 102100034397 Uroporphyrinogen-III synthase Human genes 0.000 description 1
- 208000014769 Usher Syndromes Diseases 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 201000011053 Variegate Porphyria Diseases 0.000 description 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
- 206010047741 Vulval cancer Diseases 0.000 description 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
- 208000026724 Waardenburg syndrome Diseases 0.000 description 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
- 201000002916 Warburg micro syndrome Diseases 0.000 description 1
- 201000000021 Weissenbacher-Zweymuller syndrome Diseases 0.000 description 1
- 208000018839 Wilson disease Diseases 0.000 description 1
- 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 1
- 208000031878 X-linked hypophosphatemia Diseases 0.000 description 1
- 208000035724 X-linked hypophosphatemic rickets Diseases 0.000 description 1
- 208000006756 X-linked sideroblastic anemia Diseases 0.000 description 1
- 208000022440 X-linked sideroblastic anemia 1 Diseases 0.000 description 1
- 201000006083 Xeroderma Pigmentosum Diseases 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 208000008919 achondroplasia Diseases 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000000391 adenylosuccinate lyase deficiency Diseases 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 206010001689 alkaptonuria Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 201000007945 amelogenesis imperfecta Diseases 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 201000008266 amyotrophic lateral sclerosis type 2 Diseases 0.000 description 1
- 206010002224 anaplastic astrocytoma Diseases 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001475 anti-trypsic effect Effects 0.000 description 1
- 201000011165 anus cancer Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 208000036351 autosomal dominant otospondylomegaepiphyseal dysplasia Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 208000026900 bile duct neoplasm Diseases 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 101150048834 braF gene Proteins 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000003149 breast fibroadenoma Diseases 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000005973 campomelic dysplasia Diseases 0.000 description 1
- 230000022159 cartilage development Effects 0.000 description 1
- 208000012056 cerebral malformation Diseases 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 208000004664 chromosome 18p deletion syndrome Diseases 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 208000031214 ciliopathy Diseases 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 208000025645 collagenopathy Diseases 0.000 description 1
- 208000030251 communication disease Diseases 0.000 description 1
- 208000003611 congenital autoimmune diabetes mellitus Diseases 0.000 description 1
- 208000015532 congenital bilateral absence of vas deferens Diseases 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 208000030381 cutaneous melanoma Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 208000013916 distal hereditary motor neuronopathy type 5 Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 201000008220 erythropoietic protoporphyria Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000007387 excisional biopsy Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000024519 eye neoplasm Diseases 0.000 description 1
- 108010091897 factor V Leiden Proteins 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 210000001650 focal adhesion Anatomy 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000003884 gestational trophoblastic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 201000010928 hereditary multiple exostoses Diseases 0.000 description 1
- 208000013746 hereditary thrombophilia due to congenital protein C deficiency Diseases 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 239000012478 homogenous sample Substances 0.000 description 1
- 208000003074 hypochondrogenesis Diseases 0.000 description 1
- 201000010072 hypochondroplasia Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007386 incisional biopsy Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000012880 independent component analysis Methods 0.000 description 1
- OLNJUISKUQQNIM-UHFFFAOYSA-N indole-3-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CNC2=C1 OLNJUISKUQQNIM-UHFFFAOYSA-N 0.000 description 1
- 208000005259 infantile-onset ascending hereditary spastic paralysis Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 201000004653 inflammatory breast carcinoma Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000013094 juvenile primary lateral sclerosis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000036546 leukodystrophy Diseases 0.000 description 1
- 210000002332 leydig cell Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000026807 lung carcinoid tumor Diseases 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 201000003175 male breast cancer Diseases 0.000 description 1
- 208000010907 male breast carcinoma Diseases 0.000 description 1
- 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 208000008585 mastocytosis Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 201000003694 methylmalonic acidemia Diseases 0.000 description 1
- 208000004141 microcephaly Diseases 0.000 description 1
- 230000003990 molecular pathway Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000010879 mucinous adenocarcinoma Diseases 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 201000009340 myotonic dystrophy type 1 Diseases 0.000 description 1
- 201000008709 myotonic dystrophy type 2 Diseases 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 201000004931 neurofibromatosis Diseases 0.000 description 1
- 208000022032 neurofibromatosis type 2 Diseases 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- 208000004235 neutropenia Diseases 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 201000008106 ocular cancer Diseases 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 208000002593 pantothenate kinase-associated neurodegeneration Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 208000010916 pituitary tumor Diseases 0.000 description 1
- 208000001061 polyostotic fibrous dysplasia Diseases 0.000 description 1
- 208000015768 polyposis Diseases 0.000 description 1
- 208000030266 primary brain neoplasm Diseases 0.000 description 1
- 201000008312 primary pulmonary hypertension Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 201000004012 propionic acidemia Diseases 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000023558 pseudoxanthoma elasticum (inherited or acquired) Diseases 0.000 description 1
- 238000007388 punch biopsy Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 108700042226 ras Genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000000757 red-green color blindness Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 201000005572 sensory peripheral neuropathy Diseases 0.000 description 1
- 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
- 238000007389 shave biopsy Methods 0.000 description 1
- 201000007245 sideroblastic anemia 1 Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 208000031019 skin pigmentation disease Diseases 0.000 description 1
- 239000010454 slate Substances 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000027765 speech disease Diseases 0.000 description 1
- 201000010812 spondyloepimetaphyseal dysplasia, Strudwick type Diseases 0.000 description 1
- 201000003504 spondyloepiphyseal dysplasia congenita Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000006446 thiamine-responsive megaloblastic anemia syndrome Diseases 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 206010043778 thyroiditis Diseases 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 208000026485 trisomy X Diseases 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 208000009999 tuberous sclerosis Diseases 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000023747 urothelial carcinoma Diseases 0.000 description 1
- 208000037965 uterine sarcoma Diseases 0.000 description 1
- 206010046885 vaginal cancer Diseases 0.000 description 1
- 208000013139 vaginal neoplasm Diseases 0.000 description 1
- 210000001177 vas deferen Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 208000006542 von Hippel-Lindau disease Diseases 0.000 description 1
- 201000005102 vulva cancer Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562128469P | 2015-03-04 | 2015-03-04 | |
| US201562128463P | 2015-03-04 | 2015-03-04 | |
| US62/128,463 | 2015-03-04 | ||
| US62/128,469 | 2015-03-04 | ||
| US201562238893P | 2015-10-08 | 2015-10-08 | |
| US62/238,893 | 2015-10-08 | ||
| PCT/US2016/020583 WO2016141127A1 (en) | 2015-03-04 | 2016-03-03 | Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2978442A1 true CA2978442A1 (en) | 2016-09-09 |
Family
ID=56849098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2978442A Pending CA2978442A1 (en) | 2015-03-04 | 2016-03-03 | Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180016642A1 (enExample) |
| EP (1) | EP3265588A4 (enExample) |
| JP (2) | JP2018514187A (enExample) |
| CN (2) | CN114634985A (enExample) |
| AU (1) | AU2016226253A1 (enExample) |
| CA (1) | CA2978442A1 (enExample) |
| WO (1) | WO2016141127A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| EP2806054A1 (en) | 2008-05-28 | 2014-11-26 | Genomedx Biosciences Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| EP2430574A1 (en) | 2009-04-30 | 2012-03-21 | Patientslikeme, Inc. | Systems and methods for encouragement of data submission in online communities |
| JP6078339B2 (ja) | 2009-05-07 | 2017-02-08 | ベラサイト インコーポレイテッド | 甲状腺状態の診断のための方法および組成物 |
| US20250263795A1 (en) * | 2009-05-07 | 2025-08-21 | Veracyte, Inc. | Methods for classification of tissue samples as positive or negative for cancer |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| WO2013090620A1 (en) | 2011-12-13 | 2013-06-20 | Genomedx Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| ES2945036T3 (es) | 2012-08-16 | 2023-06-28 | Veracyte Sd Inc | Pronóstico del cáncer de próstata mediante biomarcadores |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| EP3770274A1 (en) | 2014-11-05 | 2021-01-27 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
| CN109074426B (zh) | 2016-02-12 | 2022-07-26 | 瑞泽恩制药公司 | 用于检测异常核型的方法和系统 |
| US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| US20190264264A1 (en) * | 2016-10-26 | 2019-08-29 | Integrated Nano-Technologies, Inc. | Systems and methods for analyzing rna transcripts |
| AU2018210695B2 (en) | 2017-01-20 | 2024-07-18 | The University Of British Columbia | Molecular subtyping, prognosis, and treatment of bladder cancer |
| WO2018152093A1 (en) * | 2017-02-15 | 2018-08-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of diagnosing cancer using mitochondrial dna heterogeneity |
| US11873532B2 (en) | 2017-03-09 | 2024-01-16 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| WO2018205035A1 (en) | 2017-05-12 | 2018-11-15 | Genomedx Biosciences, Inc | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019023517A2 (en) * | 2017-07-27 | 2019-01-31 | Veracyte, Inc. | GENOMIC SEQUENCING CLASSIFIER |
| US12417825B2 (en) | 2017-09-15 | 2025-09-16 | Alden Scientific, Inc. | Systems and methods for collecting and analyzing comprehensive medical information |
| CN108416190A (zh) * | 2018-02-11 | 2018-08-17 | 广州市碳码科技有限责任公司 | 基于深度学习的肿瘤早期筛查方法、装置、设备及介质 |
| CN112585270B (zh) * | 2018-08-15 | 2023-12-05 | 中国科学院遗传与发育生物学研究所 | 评估或改善脑功能、学习能力或记忆力的组合物和方法 |
| AU2019356497B2 (en) * | 2018-10-08 | 2025-06-26 | Freenome Holdings, Inc. | Transcription factor profiling |
| US11894139B1 (en) * | 2018-12-03 | 2024-02-06 | Patientslikeme Llc | Disease spectrum classification |
| WO2021055517A1 (en) * | 2019-09-16 | 2021-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treatments based upon molecular characterization of breast cancer |
| GB201914193D0 (en) * | 2019-10-02 | 2019-11-13 | Aldo Faisal | Digital biomarkers of movement for diagnosis |
| JP7721538B2 (ja) | 2020-01-09 | 2025-08-12 | ホワイトラビット・エーアイ・インコーポレイテッド | リアルタイム放射線医学を行うための方法およびシステム |
| JP7570088B2 (ja) * | 2020-06-18 | 2024-10-21 | 国立研究開発法人産業技術総合研究所 | 情報処理システム、情報処理方法、同定方法及びプログラム |
| CN112326965B (zh) * | 2020-10-22 | 2022-03-04 | 南京医科大学 | Daam1蛋白在制备肾透明细胞癌诊断及预后评估试剂盒中的应用 |
| CN114622007A (zh) * | 2020-12-10 | 2022-06-14 | 深圳先进技术研究院 | 一种Cox6c检测引物及其应用 |
| US11367521B1 (en) | 2020-12-29 | 2022-06-21 | Kpn Innovations, Llc. | System and method for generating a mesodermal outline nourishment program |
| CN112715484B (zh) * | 2020-12-29 | 2022-04-22 | 四川省人民医院 | 构建视网膜色素变性疾病模型的方法、应用以及繁育方法 |
| CN113504370B (zh) * | 2021-06-29 | 2024-02-09 | 广州金研生物医药研究院有限公司 | Mapk15蛋白在前列腺癌的恶性程度或预后程度预测中的应用 |
| US20250259750A1 (en) * | 2022-04-15 | 2025-08-14 | Memorial Sloan-Kettering Cancer Center | Multi-modal machine learning to determine risk stratification |
| WO2024186815A1 (en) * | 2023-03-06 | 2024-09-12 | Exactech, Inc. | Improved computer-based joint arthroplasty system and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2765591B1 (fr) * | 1997-07-01 | 2002-08-09 | Pasteur Institut | Procede de diagnostic de la maladie d'alzheimer |
| EP1644858B1 (en) * | 2003-07-10 | 2017-12-06 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| GB0417740D0 (en) * | 2004-08-10 | 2004-09-08 | Uc3 | Methods and kit for the prognosis of breast cancer |
| US20110312520A1 (en) * | 2010-05-11 | 2011-12-22 | Veracyte, Inc. | Methods and compositions for diagnosing conditions |
| US20130303826A1 (en) * | 2011-01-11 | 2013-11-14 | University Health Network | Prognostic signature for oral squamous cell carcinoma |
| EP2771487A1 (en) * | 2011-10-27 | 2014-09-03 | Asuragen, INC. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
| JP2013212052A (ja) * | 2012-03-30 | 2013-10-17 | Yale Univ | Ｋｒａｓバリアントおよび腫瘍生物学 |
-
2016
- 2016-03-03 CN CN202210267696.9A patent/CN114634985A/zh active Pending
- 2016-03-03 CA CA2978442A patent/CA2978442A1/en active Pending
- 2016-03-03 AU AU2016226253A patent/AU2016226253A1/en not_active Abandoned
- 2016-03-03 CN CN201680026050.4A patent/CN107636171A/zh active Pending
- 2016-03-03 JP JP2017546066A patent/JP2018514187A/ja not_active Withdrawn
- 2016-03-03 WO PCT/US2016/020583 patent/WO2016141127A1/en not_active Ceased
- 2016-03-03 EP EP16759458.9A patent/EP3265588A4/en not_active Withdrawn
-
2017
- 2017-09-01 US US15/694,157 patent/US20180016642A1/en not_active Abandoned
-
2022
- 2022-01-11 JP JP2022002016A patent/JP2022050571A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016141127A1 (en) | 2016-09-09 |
| EP3265588A1 (en) | 2018-01-10 |
| CN114634985A (zh) | 2022-06-17 |
| AU2016226253A1 (en) | 2017-09-21 |
| US20180016642A1 (en) | 2018-01-18 |
| EP3265588A4 (en) | 2018-10-10 |
| JP2018514187A (ja) | 2018-06-07 |
| CN107636171A (zh) | 2018-01-26 |
| JP2022050571A (ja) | 2022-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180016642A1 (en) | Methods for assessing the risk of disease occurrence or recurrence using expression level and sequence variant information | |
| US20180349548A1 (en) | Methods and compositions that utilize transcriptome sequencing data in machine learning-based classification | |
| JP7689557B2 (ja) | 相同組換え欠損を推定するための統合された機械学習フレームワーク | |
| US12297503B2 (en) | Methods for classification of tissue samples as positive or negative for cancer | |
| JP6561046B2 (ja) | 遺伝子の変動の非侵襲性評価のための方法および処理 | |
| JP6473744B2 (ja) | 遺伝子の変動の非侵襲的評価のための方法および処理 | |
| JP6525434B2 (ja) | 遺伝子の変異の非侵襲的な評価のための方法および処理 | |
| US20230175058A1 (en) | Methods and systems for abnormality detection in the patterns of nucleic acids | |
| US20200232046A1 (en) | Genomic sequencing classifier | |
| US20180127832A1 (en) | Algorithms for Disease Diagnostics | |
| JP2021035387A (ja) | 遺伝子の変動の非侵襲的評価のための方法および処理 | |
| US20110312520A1 (en) | Methods and compositions for diagnosing conditions | |
| CA3160566A1 (en) | Systems and methods for predicting homologous recombination deficiency status of a specimen | |
| JP2016540520A (ja) | 染色体変化の非侵襲性評価のための方法およびプロセス | |
| CN116583904A (zh) | 用于癌症分类的样品确认 | |
| Quiroz-Zárate et al. | Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue | |
| US20250263795A1 (en) | Methods for classification of tissue samples as positive or negative for cancer | |
| WO2024258639A1 (en) | Methods and systems of classifying tumor tissue samples | |
| Borden et al. | Towards a transcriptomic biomarker for the classification of melanocytic neoplasms | |
| CN121153082A (zh) | 用于在全基因组测序中进行泛癌筛查的机器学习方法 | |
| HK1182452B (en) | Methods and compositions for diagnosing conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210302 |
|
| EEER | Examination request |
Effective date: 20210302 |
|
| EEER | Examination request |
Effective date: 20210302 |
|
| EEER | Examination request |
Effective date: 20210302 |
|
| EEER | Examination request |
Effective date: 20210302 |